Abstract | BACKGROUND:
Breast pain and non-discrete breast nodularity are common in women. METHODS: We did a randomized, double-blind, placebocontrolled trial of oral ormeloxifene 30 mg, a selective oestrogen receptor modulator ( SERM) or placebo twice a week for 3 months in 20-50-year-old women with breast pain with or without lumpiness. Women with a discrete benign lump or cancer were excluded from the study. Serial assessments of pain on a visual analogue scale and nodularity grade on a 5-point ordinal Lucknow-Cardiff scale were done. A total of 151 patients were randomly allocated to two interventions using a block size of 4. RESULTS: Of the 151 patients, 121 (active 57, placebo 64) were available for efficacy analysis. The mean pain level showed a systematic downward trend over five visits (F=105.23, p<0.0001) that significantly reduced in the active group compared to that in the placebo group (F=18.66, p<0.0001). The patterns of variation in pain over time for the individual groups differ from the overall mean pattern for the two groups and thus from one another (F=44.43, p<0.0001). Cumulative frequencies of breast nodularity grades during successive visits showed significant improvement (p=0.001) compared to placebo at the end of the third month. The effect of the active drug persisted till the completion (6 months) of treatment (p<0.001). At the last visit, 93.3% of women in the active group had grade 2 or lower nodularity as compared to 71.1% in the placebo group. Oligomenorrhoea alone was reported by 12 patients. CONCLUSION:
|
Authors | Sandeep Kumar, Ruchi Rai, G G Agarwal, Varsha Dwivedi, Surender Kumar, Vinita DAS |
Journal | The National medical journal of India
(Natl Med J India)
2013 Mar-Apr
Vol. 26
Issue 2
Pg. 69-74
ISSN: 0970-258X [Print] India |
PMID | 24093978
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2013, NMJI. |
Chemical References |
- Benzopyrans
- Selective Estrogen Receptor Modulators
- ormeloxifene
|
Topics |
- Adult
- Benzopyrans
(therapeutic use)
- Breast
(pathology)
- Double-Blind Method
- Female
- Humans
- Mastodynia
(drug therapy, pathology)
- Selective Estrogen Receptor Modulators
(therapeutic use)
|